Related Experiment Video
Updated: Aug 25, 2026
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
Detection of hepatitis G virus/GB virus C after allogeneic bone marrow transplantation
P Ljungman1, R Halasz, H Hägglund
1Department of Hematology, Huddinge University Hospital, Karolinska Institutet, Sweden.
Insights
Hepatitis G virus (HGV) infection before allogeneic stem cell transplant did not increase liver complications or delay engraftment. This study suggests HGV has limited impact on post-transplant outcomes.
Area of Science:
- Hepatology
- Virology
- Transplant Immunology
Background:
- Abnormal liver function post-allogeneic bone marrow transplantation (BMT) is often linked to VOD.
- Hepatitis G virus/GB virus C (HGV) is implicated in non-A-E hepatitis.
- The role of HGV in transplant complications requires further investigation.
Purpose of the Study:
- To evaluate the risk of liver complications in HGV-infected patients undergoing BMT.
- To assess the impact of HGV infection on engraftment time after BMT.
- To determine the significance of pre-transplant HGV detection.
Main Methods:
- Retrospective analysis of 50 patients who underwent BMT in 1995.
- RT-PCR testing for HGV in pre- and post-transplant samples.
- Comparison of liver function, VOD incidence, and neutrophil engraftment time between HGV-positive and HGV-negative groups.
Main Results:
- Seven out of 50 patients had detectable HGV before BMT.
- No new HGV infections occurred during or immediately after BMT.
- No significant differences were observed in liver function, VOD, or engraftment time based on HGV status.
Conclusions:
- Pre-transplant HGV infection does not appear to elevate the risk of liver complications or delayed engraftment.
- The clinical significance of HGV in the context of allogeneic BMT is limited.
- Further research may clarify the precise role of HGV in specific transplant populations.
Abstract:
Abnormal liver function before allogeneic BMT has been associated with VOD. Hepatitis G virus/GB virus C (HGV) is a recently discovered virus suggested to be a cause of non-A, non-B, non-C, non-D and non-E hepatitis. The aim of this retrospective study was to analyze the risk for liver complications and time to engraftment in patients infected with HGV. Fifty patients transplanted in 1995 were examined with RT-PCR for HGV on samples collected before, and between 3 and 6 months after BMT. Seven patients had HGV detected before BMT. No patient became infected during or early after the BMT. There were no differences in either pre- or post-transplant liver function abnormalities, VOD, or time to neutrophil engraftment in patients who did or did not have HGV detected before BMT. We conclude that the importance of HGV infection for the development of post-transplant complications is limited.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
